Florida cracks down on deadly 7-OH drug after 587 overdose deaths
Florida cracks down on deadly 7-OH drug after 587 overdose deaths
Florida cracks down on deadly 7-OH drug after 587 overdose deaths
A dangerous opioid-like chemical has been tied to hundreds of overdose deaths in Florida. Known as 7-OH, the substance has prompted urgent action from authorities to curb its spread. The drug is now classified as a Schedule I substance under emergency rules. Since 2013, 7-OH has been linked to at least 587 overdose deaths across Florida. The chemical acts on opioid receptors, leading to respiratory depression, addiction, and severe withdrawal symptoms. Its presence in products sold at gas stations and vape shops has raised alarms.
Brands such as Hydroxy, 7Tabz, and 7OHMZ have sold concentrated versions of the drug. In response, Florida introduced an emergency rule to limit 7-OH content to 1 milligram per gram or millilitre in products. Since the rule took effect, over 23,000 illegal packages have been seized from retailers.
The FDA has warned consumers to avoid 7-OH products entirely. The agency has not approved them for any medical use and has issued warning letters to companies distributing them illegally. The emergency classification now allows felony-level arrests and the shutdown of illegal sellers. The crackdown aims to reduce exposure and overdose cases, which have been rising in recent years. The classification as a Schedule I substance strengthens legal measures against its sale. Authorities continue to monitor and remove illegal products from circulation.
Florida cracks down on deadly 7-OH drug after 587 overdose deaths
A synthetic opioid called 7-OH is flooding Florida's streets, disguised in vape shops and gas stations. Now, authorities are fighting back with felony charges and mass seizures.
Kazakhstan's Top Cardiology Institute Earns Elite Hypertension Accreditation
A landmark achievement for Central Asia's medical field. How this elite designation could transform heart health research and treatment in Kazakhstan.
RQ Bio Secures Funding to Revolutionize Flu Prevention with Single-Dose Antibody
A game-changing flu therapy is on the horizon. With fresh backing from top investors, RQ Bio's RQB01 promises season-long protection—and could redefine how we fight influenza.
How UPMC's integrated system redefines excellence in cardiac care
A seamless blend of innovation and teamwork is transforming heart surgery. Discover how UPMC's model sets a new standard for hospitals nationwide.